[Primary adenocarcinoma of the male urethra. A case report]

Cancer Radiother. 2002 Dec;6(6):358-62. doi: 10.1016/s1278-3218(02)00223-8.
[Article in French]

Abstract

Primary adenocarcinoma of the male urethra is very uncommon, accounts for 5% of primary urethral cancers. All types of urethral carcinomas account for less than 1% of urinary malignancies in man. The prognosis remains poor despite the wide surgical treatment. The place of chemotherapy combined with radiotherapy must be defined by other studies. We report a case of primary locally advanced adenocarcinoma arising in the bulbo-membranous urethra. The patient was 29 years old, without any previous history of venerian disease. He was treated by combined external beam radiotherapy (total dose 67Gy) and chemotherapy (Cisplatinum). A marked reduction of tumor volume has been noted but the patient died because of the appearance of bone metastasis which failed to the systemic therapy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy*
  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Cisplatin / therapeutic use*
  • Fatal Outcome
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prognosis
  • Treatment Outcome
  • Urethral Neoplasms / drug therapy*
  • Urethral Neoplasms / pathology
  • Urethral Neoplasms / radiotherapy*

Substances

  • Antineoplastic Agents
  • Cisplatin